• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中胆碱能毒蕈碱 M/M 受体的空间变异性。

Spatial Covariance of Cholinergic Muscarinic M /M Receptors in Parkinson's Disease.

机构信息

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.

Department of Psychiatry, University of Cambridge, Herschel Smith Building for Brain & Mind Sciences, Cambridge, United Kingdom.

出版信息

Mov Disord. 2021 Aug;36(8):1879-1888. doi: 10.1002/mds.28564. Epub 2021 May 11.

DOI:10.1002/mds.28564
PMID:33973693
Abstract

BACKGROUND

Parkinson's disease (PD) is associated with cholinergic dysfunction, although the role of M1 and M4 receptors remains unclear.

OBJECTIVE

To investigate spatial covariance patterns of cholinergic muscarinic M /M receptors in PD and their relationship with cognition and motor symptoms.

METHODS

Some 19 PD and 24 older adult controls underwent I-iodo-quinuclidinyl-benzilate (QNB) (M /M receptor) and Tc-exametazime (perfusion) single-photon emission computed tomography (SPECT) scanning. We implemented voxel principal components analysis, producing a series of images representing patterns of intercorrelated voxels across individuals. Linear regression analyses derived specific M /M spatial covariance patterns associated with PD.

RESULTS

A cholinergic M /M pattern that converged onto key hubs of the default, auditory-visual, salience, and sensorimotor networks fully discriminated PD patients from controls (F  = 135.4, P < 0.001). In PD, we derived M /M patterns that correlated with global cognition (r = -0.62, P = 0.008) and motor severity (r = 0.53, P = 0.02). Both patterns emerged with a shared topography implicating the basal forebrain as well as visual, frontal executive, and salience circuits. Further, we found a M /M pattern that predicted global cognitive decline (r = 0.46, P = 0.04) comprising relative decreased binding within default and frontal executive networks.

CONCLUSIONS

Cholinergic muscarinic M /M modulation within key brain networks were apparent in PD. Cognition and motor severity were associated with a similar topography, inferring both phenotypes possibly rely on related cholinergic mechanisms. Relative decreased M /M binding within default and frontal executive networks could be an indicator of future cognitive decline. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

摘要

背景

帕金森病(PD)与胆碱能功能障碍有关,尽管 M1 和 M4 受体的作用仍不清楚。

目的

研究 PD 中胆碱能毒蕈碱 M/M 受体的空间协变模式及其与认知和运动症状的关系。

方法

19 例 PD 患者和 24 例老年对照者接受 I-碘-喹诺环定(QNB)(M/M 受体)和 Tc-外马托唑胺(灌注)单光子发射计算机断层扫描(SPECT)扫描。我们实施了体素主成分分析,产生了一系列代表个体间相关体素模式的图像。线性回归分析得出了与 PD 相关的特定 M/M 空间协变模式。

结果

一种胆碱能 M/M 模式,汇聚到默认、视听、突显和感觉运动网络的关键枢纽,可完全区分 PD 患者和对照组(F=135.4,P<0.001)。在 PD 中,我们得出了与整体认知(r=-0.62,P=0.008)和运动严重程度(r=0.53,P=0.02)相关的 M/M 模式。这两种模式都具有共同的拓扑结构,涉及基底前脑以及视觉、额叶执行和突显回路。此外,我们发现了一种可以预测整体认知下降的 M/M 模式(r=0.46,P=0.04),包括默认和额叶执行网络内相对减少的结合。

结论

在 PD 中,胆碱能毒蕈碱 M/M 调节在关键脑网络中是明显的。认知和运动严重程度与类似的拓扑结构相关,推断这两种表型可能依赖于相关的胆碱能机制。默认和额叶执行网络内相对减少的 M/M 结合可能是未来认知下降的一个指标。

相似文献

1
Spatial Covariance of Cholinergic Muscarinic M /M Receptors in Parkinson's Disease.帕金森病中胆碱能毒蕈碱 M/M 受体的空间变异性。
Mov Disord. 2021 Aug;36(8):1879-1888. doi: 10.1002/mds.28564. Epub 2021 May 11.
2
Cholinergic muscarinic M/M receptor networks in dementia with Lewy bodies.路易体痴呆中的胆碱能毒蕈碱M/M受体网络
Brain Commun. 2020 Jul 15;2(2):fcaa098. doi: 10.1093/braincomms/fcaa098. eCollection 2020.
3
Cholinergic and perfusion brain networks in Parkinson disease dementia.帕金森病痴呆中的胆碱能与灌注脑网络
Neurology. 2016 Jul 12;87(2):178-85. doi: 10.1212/WNL.0000000000002839. Epub 2016 Jun 15.
4
Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.使用(R,R)[(123)I]-QNB单光子发射计算机断层扫描(SPECT)研究阿尔茨海默病中毒蕈碱型乙酰胆碱受体的区域协方差
J Neurol. 2015 Sep;262(9):2144-53. doi: 10.1007/s00415-015-7827-z. Epub 2015 Jun 30.
5
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.路易体痴呆、帕金森病和阿尔茨海默病中基底神经节的毒蕈碱受体
J Chem Neuroanat. 2003 Mar;25(3):161-73. doi: 10.1016/s0891-0618(03)00002-4.
6
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.纹状体胆碱能中间神经元以及M1和M4毒蕈碱受体在帕金森病运动症状中的作用
J Neurosci. 2016 Aug 31;36(35):9161-72. doi: 10.1523/JNEUROSCI.0873-16.2016.
7
A spatial covariance I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease.一项关于阿尔茨海默病中α4β2烟碱型受体的空间协方差I-5IA-85380单光子发射计算机断层扫描研究。
Neurobiol Aging. 2016 Nov;47:83-90. doi: 10.1016/j.neurobiolaging.2016.07.017. Epub 2016 Jul 30.
8
Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.帕金森病各认知领域的胆碱能神经支配模式。
Mov Disord. 2021 Mar;36(3):642-650. doi: 10.1002/mds.28360. Epub 2020 Nov 2.
9
Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.使用(R,R)123I-QNB单光子发射计算机断层扫描评估阿尔茨海默病中的毒蕈碱型乙酰胆碱受体状态。
J Neurol. 2007 Jul;254(7):907-13. doi: 10.1007/s00415-006-0473-8. Epub 2007 Mar 14.
10
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment.新发帕金森病伴或不伴认知障碍时胆碱能神经支配的改变
Mov Disord. 2022 Apr;37(4):713-723. doi: 10.1002/mds.28913. Epub 2022 Jan 17.

引用本文的文献

1
Molecular connectivity studies in neurotransmission: a scoping review.神经传递中的分子连接性研究:一项范围综述
Imaging Neurosci (Camb). 2025 Apr 4;3. doi: 10.1162/imag_a_00530. eCollection 2025.
2
Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach.帕金森病临床试验中的正电子发射断层扫描成像:代谢脑网络方法的应用
Mov Disord. 2025 Aug;40(8):1511-1527. doi: 10.1002/mds.30231. Epub 2025 May 29.
3
Neuroimaging Biomarkers in Parkinson's Disease.帕金森病的神经影像学标志物。
Adv Neurobiol. 2024;40:617-663. doi: 10.1007/978-3-031-69491-2_21.
4
Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunction.帕金森病中的视幻觉:聚焦中枢胆碱能功能障碍
Brain. 2025 Feb 3;148(2):376-393. doi: 10.1093/brain/awae289.
5
Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome.基于体素的形态计量学揭示 22q11.2 缺失综合征的结构性脑模式异常。
Hum Brain Mapp. 2024 Jan;45(1):e26553. doi: 10.1002/hbm.26553.
6
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches.帕金森病胆碱能系统改变:新兴治疗方法。
Lancet Neurol. 2022 Apr;21(4):381-392. doi: 10.1016/S1474-4422(21)00377-X. Epub 2022 Feb 4.